HIV Patients
In a randomized,
double-blind, multicenter trial of 59 HIV positive subjects, researchers
studied the effect of high protein whey supplementation when compared to a matched
isocaloric control supplement without added protein for patients with a history
of weight loss (a typical and potentially dangerous factor for HIV positive
patients).7 Following the 12-week study, researchers concluded that
there was no observed difference in regard to increased energy intake or
changes in weight/lean body mass.7 However, researchers stated that
CD4 lymphocytes (white blood cells responsible for fighting bacteria, viruses
and germs) did increase in the protein group, a potential benefit according to
the authors.7 However, researchers also stated that gastrointestinal
symptoms were more commonly reported in the high protein whey group.7 It is important to note
that this study was supported by the whey supplement company, drawing into
question the validity of accurate findings.7
A 1999 three-arm
randomized controlled trial of 536 HIV patients with CD4 counts below 200
looked at the impact of nutrients on the prevention of weight loss over a
four-month period.8 Researchers
studied the implementation of three nutritional regimens to determine
their effect on the prevention of weight loss in patients.8 Therapies
consisted of a 500 kcal daily of caloric
supplement with peptides and medium-chain triglycerides plus a multivitamin and
mineral supplement, 500 kcal of a caloric supplement with whole protein and
long-chain triglycerides plus a multivitamin and mineral supplement, and a
multivitamin and mineral supplement only.8 At the conclusion of the
four-month study, researchers concluded that no differences were observed
(including the increased protein group), stating that caloric supplements did
not provide a viable treatment modality for this population.8
In a 2003 study of
467 weight-stable HIV-infected men with CD4 counts lower than 200 were observed
in regard to protein intake and body composition variables, including body cell
mass (the depletion of which is a predictor of disease progression and death).9
Researchers concluded that increased protein intake was related to increased
body cell mass, suggesting efficacy in the use of protein to boost health
variables in HIV patients.9
Researchers in a
2006 study of children suffering from rapidly-progressing AIDS, examined the
effect of a whey protein supplement in
regard to erythrocyte glutathione concentration, T
lymphocyte counts and occurrence of additional infections.10 In
the prospective double-blind clinical trial, 18 HIV-infected children
undergoing antiretroviral therapy were followed for four months.10
The subjects were divided into three groups and given whey protein,
maltodextrin or placebo, followed by an evaluation of erythrocyte glutathione
concentration, T lymphocyte counts and occurrence of additional infections.10
Results demonstrated that in the whey
protein group, erythrocyte glutathione levels increased and co-infection
occurrence decreased, while T lymphocytes remained unchanged when compared to
the control group (placebo).10 Researchers
concluded that the inclusion of a whey protein supplement was advisable for
this population.10
Summary of Findings and
Limitations
Though this brief
review may appear to point to the overall benefits of increased protein intake
and health-compromised people groups, it is important to note the existence of
study limitations. Several of the studies reviewed involved very small sample sizes.
Though this fact does not necessarily fully discount the findings, it does give
reason to be cautious when evaluating the efficacy of information. Many of the
studies reviewed also examined multiple factors combined with increased protein
intake, making the definitive factor of efficacy more difficult to deduce. Further,
as mentioned previously, one of the studies presented was funded by the maker
of the protein supplement used in the study, thus giving reason to again be
mindful of the bias potential. Length of the studies is also a factor to
consider due to the fact that the relevance of data was not studied extensively
in terms of long-term outcomes. Oftentimes interventions appear positive in the
short-term but neutral or negative in the long-term. Further, though some
benefit was shown in some of the presented studies, it is important to note
that reduction in wound size or increased levels of CD4 levels for example,
does not necessarily imply positive health outcomes for the individual overall.
Symptom management, symptom reduction and more acceptable biomarkers do not
always suggest optimal health, a point of key importance when evaluating
treatment modalities.
Risks
It is always
important to examine the level of risk associated with any type of intervention,
even if the added measure appears to be harmless. Though protein is a necessary
nutrient, an increase of consumption does not come without risk. Consuming
large amounts of protein carries with it a significant amount of risk such as
increased risk of cancer, diabetes and overall mortality.11 Eating a
high protein diet also creates excessive strain on the kidneys, causing
complications such as the formation of kidney stones and other kidney-related
health issues.13 In addition, the inclusion of high protein
supplements made from dairy products carries with it a considerable amount of
risk due to the detrimental effects of dairy consumption. Higher mortality
rates, cancer, fracture risk and heart disease can all be linked to the
consumption of dairy, a fact that should give significant pause to the
recommendation to increase the consumption of it, particularly in
immune-compromised populations.,14, 15, 16
Conclusions and Future Research
Opportunities
As reviewed above,
some evidence appears to exist in regard to increased protein intake. However,
study limitations exist and multiple risks exist to the implementation of
increased protein intake. Additional research into alternative methods of
improvement that do not involve increased protein intake would be wise to
conduct, in addition to a more extensive evaluation of the risk-benefit ratio
of protein intervention and the detrimental effects of engaging in such
measures.
References
7. Sattler FR, Rajicic N, Mulligan
K, et al. Evaluation of high-protein supplementation in weight-stable
HIV-positive subjects with a history of weight loss: a randomized, double-blind,
multicenter trial. American Journal of Clinical Nutrition.
2008;88(5):1313–1321. doi:10.3945/ajcn.2006.23583
8. Gibert CL, Wheeler DA, Collins
G, et al. Terry Beirn Community Programs for Clinical Research on AIDS:
randomized, controlled trial of caloric supplements in HIV infection. Journal
of Acquired Immune Deficiency Syndrome. 1999;22:253–259.
9. Williams SB, Bartsch G,
Muurahainen N, et al. Protein intake is positively associated with body cell
mass in weight-stable HIV-infected men. Journal of Nutrition. 2003; 133(4):
1143-1146.
10. Moreno YF, Sgarbieri VC,
da Silva MN, Toro AADC, Vilela MMS. Features of whey protein concentrate
supplementation in children with rapidly progressive HIV infection. Journal of
Tropical Pediatrics. 2006; 52(1): 34–38.
11. Levine ME, Suarez JA,
Brandhorst S, et al. Low protein intake is associated with a major reduction in
IGF-1, cancer, and overall mortality in the 65 and younger but not older
population. Cell Metabolism. 2014;19(3):407–417.
12. Fontana L, Klein S, O Holloszy
J, Long-term low-protein, low-calorie diet and endurance exercise modulate
metabolic factors associated with cancer risk. American Journal of Clinical
Nutrition. 2006; 84(6):1456–1462.
13. Robertson W, Heyburn P, Peacock
M, Hanes F, Swaminathan R. The effect of high animal protein intake on the risk
of calcium stone-formation in the urinary tract. Clinical Science. 1979;
57(3):285-288.
14. Michaƫlsson K, Wolk A,
Langenskiƶld S, et al. Milk intake and risk of mortality and fractures in women
and men: cohort studies. British Medical Journal. 2014; 349 :6015.
15. Aune D, Rosenblatt DAN, Chan
DSM, et al. Dairy products, calcium, and prostate cancer risk: a systematic
review and meta-analysis of cohort studies. American Journal of Clinical
Nutrition. 2015;101:87-117.
16. Chen M, Li Y, Sun
Q, et al. Dairy fat and risk of cardiovascular disease in 3 cohorts of US
adults. American Journal of Clinical Nutrition. 2016;104(5):1209–1217.
No comments:
Post a Comment